It is seen that transforming growth factor-beta (TGF-β) acts via IL-6 to activate the signal transducer and activator of transcription-3 (STAT-3) in the tumor cells, which requires the soluble IL-6 receptor present in the tumor cells [51]. The gene discussed is TGFB1; the disease is neoplasm.